Tag: Sandoz
Sandoz to acquire biosimilar CIMERLI from Coherus BioSciences to expand ophthalmology portfolio
In a significant development within the pharmaceutical and healthcare industry, Sandoz, a global leader in generic and biosimilar medicines, announced its strategic acquisition of the ... Read More
Sandoz and Biocon Biologics sign distribution deal for key immunology drug
Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd and a prominent player in the global biosimilars market, has entered into a pivotal Distribution Agreement ... Read More
Sandoz to acquire GSK’s cephalosporin antibiotics business in $500m worth deal
Sandoz, a division of Swiss pharma giant Novartis, has agreed to acquire GSK’s cephalosporin antibiotics business in a deal worth up to $500 million. The ... Read More
Novartis’ Sandoz to acquire Aspen’s Japanese pharma business
Sandoz, the generic drug business of Novartis has agreed to acquire the Japanese business of Aspen Global Incorporated (AGI), a fully owned subsidiary of Aspen ... Read More
US CDMO Avara acquires sterile manufacturing facility in Boucherville from Sandoz
Avara Pharmaceutical Services, a US CDMO (contract development and manufacturing organization), has completed a previously announced acquisition of a Canadian sterile manufacturing facility for injectable ... Read More
Hyrimoz EC approval : Novartis biosimilar of AbbVie Humira approved in EU
Hyrimoz EC approval : Novartis’ Sandoz has bagged approval for Hyrimoz (adalimumab), a biosimilar of AbbVie’s Humira (adalimumab), in Europe for all indications of the ... Read More
Slayback Pharma launches genital herpes ointment – Zovirax Ointment 5%
Slayback Pharma has launched its genital herpes ointment Generic Zovirax Ointment (Acyclovir Ointment) 5% in the US. The launch of the genital herpes ointment was ... Read More